Mice that lack a protein called AMPK in the muscle around their blood vessels develop a lethal disease that appears…
Articles by Marisa Wexler, MS
Scores on standardized risk assessments showed a clear treatment effect with Orenitram (treprostinil) after three months in a…
The European Society of Cardiology (ESC) and the European Respiratory Society (ERS) have published a new set of guidelines for…
More than half of babies born preterm at a center in the Netherlands were found to have pulmonary hypertension…
Treatment with Adempas (riociguat) improved blood flow measurements in people with pulmonary hypertension and heart failure with preserved…
Diagnostic testing plays an important role in guiding changes in treatment for children with pulmonary arterial hypertension (PAH), suggesting…
Yutrepia, an inhaled formulation of treprostinil, was generally well tolerated and improved the quality of life for people with…
More than half of people with pulmonary arterial hypertension (PAH) who start daily treatment with oral Opsumit (macitentan)…
Treatment with Uptravi (selexipag) significantly improved blood flow parameters in people with inoperable or persistent chronic thromboembolic pulmonary…
Among people with chronic thromboembolic pulmonary hypertension (CTEPH), risk assessments and treatment patterns prior to surgical procedures do not…
Levels of the protein TXNRD1 are reduced in the blood of people with idiopathic pulmonary arterial hypertension (IPAH), suggesting…
The U.S. Food and Drug Administration (FDA) has approved LungFit PH, Beyond Air‘s device to administer nitric oxide therapy,…